Butler Hospital
Providence, Rhode Island, 02906, United States
NCT Number: NCT04667520
The primary aim of this project is to test the efficacy of a technology-supported lifestyle physical activity (LPA) intervention for preventing relapse among women with depression engaged in alcohol treatment. Participants are randomized to either 1) LPA+Fitbit intervention or 2) Fitbit Only control condition. Follow-up assessments and EMA data will be collected.
This study is active but is not currently recruiting participants.
18 year–65 year
Female
Interventional
Not applicable
Providence, Rhode Island, 02906, United States
Alcohol use disorder (AUD) is a significant and costly public health problem that affects one-third of the U.S. population in their lifetime. Women develop AUD more quickly and suffer a broader range of adverse alcohol-related health consequences than men. Physical activity (PA) interventions may play an important role as an alternate coping strategy for women with AUD and a means to decrease relapse.
The primary aim of this project is to test the efficacy of a technology-supported lifestyle physical activity (LPA) intervention for preventing relapse among women with depression engaged in alcohol treatment. A total of 214 women from the Alcohol and Drug Partial Hospitalization Program (ADP) at Butler Hospital with AUD and depression will be recruited and randomly assign them to either a: 1) LPA+Fitbit intervention or 2) Fitbit Only control condition. Follow-up assessments will occur at 6-weeks, end of treatment (EOT) at 3 months, and 6, 9 and 12 months. Participants will also complete 3, 10-day periods of ecological momentary assessment (EMA) during early recovery, at approximately weeks 1 & 2, 5 & 6, and again at weeks 11 & 12.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention has 3 components: (1) an orientation session to LPA and using the Fitbit; (2) Six telephone physical activity counseling sessions; and (3) monitoring activity with the Fitbit, which is provided to them during their study participation.
Participants are provided with a Fitbit during their study participation.
Time frame: 12 months
Timeline Follow-back Interview will be used to determined whether participants drank any alcohol during the time frame assessed.
Time frame: 12 months
The Short Inventory of Problems will be used to measure the experience of alcohol-related consequences during the study period.
Time frame: 12 months
Symptoms of depression, as measured by the Patient Health Questionnaire-9
Time frame: 12 months
Objectively measured steps/day with a Fitbit
Time frame: 12 months
Alcohol abstinence self-efficacy, as measured by Alcohol Abstinence Self-Efficacy Scale
Time frame: 12 months
Estimated VO2 max will be determined by the 6-minute Cycle Ergometer Exercise test
Butler Hospital
Other
Acronym: HEART
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06090422
Alcohol Use Disorder, Alcohol-Related Disorders
Tromsø, Norway
View Trial DetailsNCT04356274
Alcohol Use Disorder, Alcohol-Related Disorders
Palo Alto, California, United States
View Trial DetailsNCT06290778
Alcohol Use Disorder, Alcohol-Related Disorders
Waco, Texas, United States
View Trial DetailsNCT03517878
Acquired Immunodeficiency Syndrome, Alcohol Drinking
Mqanduli, Eastern Cape, South Africa
View Trial Details